SARAH VOGELFANGER: Open Payments
NPI 1356850283 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,545 in 159 payments from 17 companies in 2025. Trend: 2023 $21,757 · 2024 $14,240 · 2025 $10,545
Speaker / faculty: $7,500Food & beverage: $3,020Travel & lodging: $25
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $7,995 |
| Axsome Therapeutics, Inc. | 22 | $507 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $439 |
| Alkermes, Inc. | 16 | $340 |
| Vanda Pharmaceuticals Inc. | 17 | $314 |
| Otsuka America Pharmaceutical, Inc. | 19 | $229 |
| Neurocrine BioSciences, Inc. | 9 | $162 |
| Collegium Pharmaceutical, Inc. | 9 | $139 |
| Supernus Pharmaceuticals, Inc. | 6 | $112 |
| Lundbeck LLC | 4 | $92 |
Products named: VRAYLAR, Auvelity, CAPLYTA, ARISTADA, REXULTI, HETLIOZ, INGREZZA, Jornay PM.
Industry payments across TN — which companies pay providers there.
